We read with interest the excellent review by Scott and colleagues1 on the contribution of sarcopenia to type 2 diabetes in the ageing Australian population. In a prospective Australian cohort of community-dwelling men, we recently found that muscle grip strength and muscle quality, but not muscle mass, were associated with incident type 2 diabetes at 5 years follow-up.2 These associations were not mediated by serum interleukin 6 or tumour necrosis alpha.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Scott D, de Courten B, Ebeling PR. Sarcopenia: a potential cause and consequence of type 2 diabetes in Australia’s ageing population? Med J Aust 2016; 205: 329-333. <MJA full text>
- 2. Li JJ, Wittert GA, Vincent A, et al. Muscle grip strength predicts incident type 2 diabetes: population-based cohort study. Metabolism 2016; 65: 883-892.
- 3. Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 2014; 69: 547-558.
The Men Androgen Inflammation Lifestyle Environment and Stress cohort study has been supported by the National Health and Medical Research Council of Australia (grant no. 627227), the University of Adelaide, the South Australian Department of Health, the Florey Foundation and the South Australian Premier’s Science and Research Fund.
Robert Adams has received research funding from the National Health and Medical Research Council of Australia and the ResMed Foundation, and equipment donations from Embla Systems.